SCHEDULE: BlackRock Reduces AVITA Medical Stake Below 5%

BlackRock, Inc. has reported a beneficial ownership of 4.3% in AVITA Medical, Inc. common stock, holding 1,138,436 shares.

Summary

• BlackRock, Inc. filed an Amendment No. 1 to Schedule 13G, reporting its beneficial ownership in AVITA Medical, Inc.
• As of the event date of September 30, 2025, BlackRock beneficially owned 1,138,436 shares of AVITA Medical's common stock.
• This represents 4.3% of the total outstanding common stock of AVITA Medical, Inc.
• BlackRock holds sole voting power over 1,119,786 shares and sole dispositive power over 1,138,436 shares.
• No shared voting or dispositive power is reported.
• The filing indicates that BlackRock's interest is less than 5% of the class, consistent with a Schedule 13G filing for passive investors.

Sentiment

Score: 4

Explanation: The filing is a factual disclosure of beneficial ownership. While the reduction below 5% could be interpreted negatively by the market, the filing itself is a routine compliance document without explicit positive or negative commentary on the issuer's performance.

Positives

• NA

Negatives

• NA

Risks

• NA

Future Outlook

No forward-looking statements or guidance for AVITA Medical, Inc. are provided in this beneficial ownership filing.

Management Comments

• BlackRock, Inc. certifies that, to the best of its knowledge and belief, the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Industry Context

This filing is a routine disclosure by a major institutional asset manager, BlackRock, Inc., regarding its passive investment stake in a publicly traded company. Such filings provide transparency on significant institutional holdings, which are common across various industries.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's passive stake, indicating a reduction below the 5% reporting threshold.

Key Dates

Recommendation

This Schedule 13G Amendment No. 1 indicates BlackRock, Inc. now holds 4.3% of AVITA Medical, Inc. common stock, falling below the 5% beneficial ownership threshold. This suggests a reduction from a previously higher stake, as Schedule 13G is typically used for passive investors holding less than 5%. While a major institutional investor reducing its position below a key reporting threshold can be interpreted as a cautious signal, the filing itself does not provide sufficient operational or financial details about AVITA Medical to warrant a strong buy or sell recommendation. The implied reduction in a significant institutional stake warrants a 'hold' recommendation, advising investors to monitor future developments and company performance.

Keywords

AVITA Medical, BlackRock, Schedule 13G, beneficial ownership, common stock, institutional investment